The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Severe Hypoglycemia and Risks of Vascular Events and Death
Open accessAbstract
BACKGROUND: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diabetes assigned to an intensive glucose-lowering intervention. We analyzed data from a large study of intensive glucose lowering to explore the relationship between severe hypoglycemia and adverse clinical outcomes. METHODS: We examined the associations between severe hypoglycemia and the risks of macrovascular or microvascular events and death among 11,140 patients with type 2 diabetes, using Cox proportional-hazards models with adjustment for covariates measured at baseline and after randomization. RESULTS: During a median follow-up period of 5 years, 231 patients (2.1%) had at least one severe hypoglycemic episode; 150 had been assigned to intensive glucose control (2.7% of the 5571 patients in that group), and 81 had been assigned to standard glucose control (1.5% of the 5569 patients in that group). The median times from the onset of severe hypoglycemia to the first major macrovascular event, the first major microvascular event, and death were 1.56 years (interquartile range, 0.84 to 2.41), 0.99 years (interquartile range, 0.40 to 2.17), and 1.05 years (interquartile range, 0.34 to 2.41), respectively. During follow-up, severe hypoglycemia was associated with a significant increase in the adjusted risks of major macrovascular events (hazard ratio, 2.88; 95% confidence interval [CI], 2.01 to 4.12), major microvascular events (hazard ratio, 1.81; 95% CI, 1.19 to 2.74), death from a cardiovascular cause (hazard ratio, 2.68; 95% CI, 1.72 to 4.19), and death from any cause (hazard ratio, 2.69; 95% CI, 1.97 to 3.67) (P<0.001 for all comparisons). Similar associations were apparent for a range of nonvascular outcomes, including respiratory, digestive, and skin conditions (P<0.01 for all comparisons). No relationship was found between repeated episodes of severe hypoglycemia and vascular outcomes or death. CONCLUSIONS: Severe hypoglycemia was strongly associated with increased risks of a range of adverse clinical outcomes. It is possible that severe hypoglycemia contributes to adverse outcomes, but these analyses indicate that hypoglycemia is just as likely to be a marker of vulnerability to such events. (Funded by Servier and the National Health and Medical Research Council of Australia; ClinicalTrials.gov number, NCT00145925.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the frequency of severe hypoglycemia in these trials was 2 to 3 times higher in the intensive therapy groups”
From Targets for Glycemic Control (2018) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with type 2 diabetes and established, or very high risk for, cardiovascular disease (CVD), there is a clear association between an increased mortality and severe hypoglycemia (62,63) and symptomatic hypoglycemia (64).”
From Hypoglycemia (2018) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Post hoc analysis of clinical trials examining the effects of strict glycemic control on cardiovascular outcomes showed that exposure to severe hypoglycemia was strongly associated with a range of adverse outcomes, including death (2, 3).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
The cited source says what the claim attributes to it.
In the citing paper
“a higher mortality was reported in participants with 1 or more episodes of severe hypoglycemia in the ACCORD (30), ADVANCE (31) and VADT trials (25), irrespective of the different treatment arms in which individual participants were allocated.”
From Targets for Glycemic Control (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [77]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“U500 regular insulin (contains 500 units/mL of regular insulin) may improve glycemia in the therapy of persons with DM who have severe insulin resistance (eg, require >200 total units of insulin/day).1102–1105”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1105]
Experimental — accuracy not yet measuredIn the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [197]
In the citing paper
“All three trials clearly demonstrated that an episode of severe hypoglycemia was associated with an increased risk of subsequent mortality.”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial (90).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Rovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120
Patel, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61303-8 · Cited by 2,054
Self-citationIntensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Self-citationGerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Flagged first, then by citations
Research works printed but not linked: 3
- Therneau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York: Springer, 2000.
- Hoekstra JBL, 2009, Diabetologia, 52, 237
- Miller ME, 2009, Diabetologia, 52, 63
Cited by
Sorted by citations
Items 301–400 of 1,002
Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study
Kar, P., Plummer, M. P., Bellomo, R., Jenkins, A. J., Januszewski, A. S., Chapman, M. J., Jones, K. L., Horowitz, M., & Deane, A. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001815 · Cited by 52
Nyström, T., Bodegård, J., Nathanson, D., Thuresson, M., Norhammar, A., & Eriksson, J. W. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.12.004 · Cited by 52
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Fullerton, B., Berghold, A., Jeitler, K., & Siebenhofer, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009122 · Cited by 51
Liu, W., Zhang, Y., Zheng, M., Ye, Y., Shi, M., Wang, X., Cao, L., & Wang, L. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156027 · Cited by 52
Holstein, A., Beil, W., & Kovacs, P. L. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.722619 · Cited by 50
Borzı̀, V., Frasson, S., Gussoni, G., Lillo, M., Gerloni, R., Augello, G., Gulli, G., Ceriello, A., Solerte, B., Bonizzoni, E., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.01.020 · Cited by 52
Seino, Y., Yabe, D., Sasaki, T., Fukatsu, A., Imazeki, H., Ochiai, H., & Sakai, S. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12694 · Cited by 50
Hypoglycemia: New Definitions and Regulatory Implications
Ratner, R. E. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0113 · Cited by 52
Lee, C. J., Brown, T. T., Schweitzer, M., Magnuson, T., & Clark, J. M. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.01.028 · Cited by 49
Risk of hypoglycemia following hospital discharge in patients with diabetes and acute kidney injury
Hung, A. M., Siew, E. D., Wilson, O. D., Perkins, A. M., Greevy, R. A., Horner, J., Abdel-Kader, K., Parr, S. K., Roumie, C. L., Griffin, M. R., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1237 · Cited by 49
Abdelhafiz, A. H., Koay, L., & Sinclair, A. J. (2016) · Future Science OA · doi:10.4155/fsoa-2015-0016 · Cited by 53
Hunt, L. M., Kreiner, M., & Brody, H. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1380 · Cited by 49
Christiansen, S. C., Fougner, A. L., Stavdahl, Ø., Kölle, K., Ellingsen, R., & Carlsen, S. M. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0263-6 · Cited by 50
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies
McGill, J. B., & Ahmann, A. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0090 · Cited by 49
Hypoglycemia in People with Type 2 Diabetes and CKD
Ahmad, I., Zelnick, L. R., Batacchi, Z. O., Robinson, N., Dighe, A. L., Manski-Nankervis, J.-A. E., Furler, J., O'Neal, D. N., Little, R. R., Trence, D., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11650918 · Cited by 49
Buehler, A. M., Cavalcanti, A. B., Berwanger, O. B., Figueiró, M. F., Laranjeira, L. N., Zazula, A. D., Kioshi, B., Bugano, D. D. G., Santucci, E. V., Sbruzzi, G., et al. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00308.x · Cited by 48
Effect of a Computerized Insulin Dose Calculator on the Process of Glycemic Control
Dumont, C., & Bourguignon, C. M. (2012) · American Journal of Critical Care · doi:10.4037/ajcc2012956 · Cited by 49
Takao, T., Suka, M., Yanagisawa, H., Matsuyama, Y., & Iwamoto, Y. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.027 · Cited by 48
Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient‐centered review
Johnson‐Rabbett, B., & Seaquist, E. R. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12933 · Cited by 51
Cardiovascular Benefits of Exogenous Insulin
Chaudhuri, A., Dandona, P., & Fonseca, V. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1112 · Cited by 49
Severe Hypoglycemia and Mortality After Cardiovascular Events for Type 1 Diabetic Patients in Sweden
Lung, T. W.-C., Petrie, D., Herman, W. H., Palmer, A. J., Svensson, A., Eliasson, B., & Clarke, P. (2014) · Diabetes Care · doi:10.2337/dc14-0405 · Cited by 47
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes
Bailey, C. J., Aschner, P. J., Prato, S. D., LaSalle, J. R., Ji, L., Matthaei, S., & Management, O. B. O. T. G. P. F. E. D. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113490765 · Cited by 48
Namba, M., Iwakura, T., Nishimura, R., Akazawa, K., Matsuhisa, M., Atsumi, Y., Satoh, J., & Yamauchi, T. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12790 · Cited by 47
Hypoglycaemia and cardiac arrhythmias in diabetes
Andersen, A., Jørgensen, P. G., Knop, F. K., & Vilsbøll, T. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820911803 · Cited by 48
Misra-Hebert, A. D., Pantalone, K. M., Ji, X., Milinovich, A., Dey, T., Chagin, K. M., Bauman, J. M., Kattan, M. W., & Zimmerman, R. S. (2018) · Diabetes Care · doi:10.2337/dc17-1834 · Cited by 46
Update on the management of diabetes in long-term care facilities
Idrees, T., CASTRO-REVOREDO, I. A., Migdal, A. L., MORENO, E. M., & Umpierrez, G. E. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002705 · Cited by 49
Kuroda, M., Shinke, T., Sakaguchi, K., Otake, H., Takaya, T., Hirota, Y., Osue, T., Kinutani, H., Konishi, A., Takahashi, H., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0236-x · Cited by 46
Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
Geng, J., Yu, H., Mao, Y., Zhang, P., & Chen, Y. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0266-y · Cited by 46
Jeon, H. J., & Oh, T. K. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.529 · Cited by 46
Montilla, S., Marchesini, G., Sammarco, A., Trotta, M. P., Siviero, P. D., Tomino, C., Melchiorri, D., & Pani, L. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.07.014 · Cited by 46
Hung, Y., Lin, C., Chen, H.-J., Chang, M. P., Huang, K. C., Chen, Y.-J., & Chen, C.-C. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4021-4 · Cited by 48
Horii, T., Oikawa, Y., Kunisada, N., Shimada, A., & Atsuda, K. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001856 · Cited by 47
Andersen, A., Bagger, J. I., Sørensen, S. K., BALDASSARRE, M. P. A., Pedersen‐Bjergaard, U., Forman, J. L., Gislason, G., Lindhardt, T. B., Knop, F. K., & Vilsbøll, T. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01425-0 · Cited by 45
Lee, S. A., Cho, S. J., Jeong, M. H., Kim, Y., Kim, C. J., Cho, M., Kim, H.-S., Ahn, Y., Koh, G., Lee, J. M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2856 · Cited by 45
Avogaro, A., Dardano, A., de Kreutzenberg, S. V., & Prato, S. D. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12319 · Cited by 45
Kajihara, N., Kukidome, D., Sada, K., Motoshima, H., Furukawa, N., Matsumura, T., Nishikawa, T., & Araki, E. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12678 · Cited by 46
Association between BMI and risk of severe hypoglycaemia in type 2 diabetes
Yun, J., Park, Y., Han, K., Cha, S., Ahn, Y., & Ko, S. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.03.006 · Cited by 45
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults
Williams, M. J., Akram, M., Barkauskaite, D., Patil, S., Kotsidou, E., Kheder, S., Vitale, G., Filaferro, M., Wanderoy, S., Maestri, G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914037117 · Cited by 45
Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.05.004 · Cited by 46
Tsujimoto, T., Yamamoto‐Honda, R., Kajio, H., Kishimoto, M., Noto, H., Hachiya, R., Kimura, A., Kakei, M., & Noda, M. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0640-9 · Cited by 45
Zhang, X.-W., Zhang, X.-L., Xu, B., & Kang, L.-N. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1107-1 · Cited by 44
Kulozik, F., & Hasslacher, C. (2013) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018813501188 · Cited by 44
Khunti, K. K., Fisher, H., Paul, S. K., Iqbal, M., Davies, M. J., & Siriwardena, A. N. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.01.001 · Cited by 44
Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
Mima, A. (2015) · Journal of Diabetes Research · doi:10.1155/2016/1379274 · Cited by 46
Chu, Y.-W., Lin, H.-M., Wang, J.-J., Weng, S., Lin, C., & Chien, C.-C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174601 · Cited by 45
Thieu, V. T., Mitchell, B. D., Varnado, O. J., & Frier, B. M. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13941 · Cited by 45
Valente, T., & Arbex, A. K. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200716201550 · Cited by 44
Giménez, M., Gómez, J. J. L., Castell, C., & Conget, I. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.01.014 · Cited by 43
Hypoglycemia-Associated Autonomic Failure in Diabetes: Maladaptive, Adaptive, or Both?
Cryer, P. E. (2015) · Diabetes · doi:10.2337/db15-0331 · Cited by 43
Saremi, A., Bahn, G., & Reaven, P. D. (2016) · Diabetes Care · doi:10.2337/dc15-2107 · Cited by 43
Understanding the impact of hypoglycemia on the cardiovascular system
Davis, I., Ahmadizadeh, I., Randell, J., Younk, L. M., & Davis, S. N. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1275960 · Cited by 44
Practical Recommendations for Transitioning Patients with Type 2 Diabetes from Hospital to Home
Donihi, A. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0876-1 · Cited by 44
Carlson, A. L., Kanapka, L. G., Miller, K. M., Ahmann, A. J., Chaytor, N. S., Fox, S., Kiblinger, L., Kruger, D., Levy, C. J., Peters, A. L., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819894974 · Cited by 43
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Chawla, R., Madhu, S. V., Makkar, B. M., Ghosh, S. K., Saboo, B., Kalra, S., & On behalf of RSSDI-ESI Consensus Group (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00819-2 · Cited by 44
Roberts, G. W., Aguilar‐Loza, N., Esterman, A., Burt, M. G., & Stranks, S. N. (2012) · Medical Journal of Australia · doi:10.5694/mja11.10853 · Cited by 42
Seidu, S., Achana, F. A., Gray, L. J., Davies, M. J., & Khunti, K. (2015) · Diabetic Medicine · doi:10.1111/dme.12885 · Cited by 44
Surgery in the treatment of type 2 diabetes mellitus
Maleckas, A., Venclauskas, L., Wallenius, V., Lönroth, H., & Fändriks, L. (2015) · Scandinavian Journal of Surgery · doi:10.1177/1457496914561140 · Cited by 43
Basal Glucose Can Be Controlled, but the Prandial Problem Persists—It’s the Next Target!
Riddle, M. C. (2017) · Diabetes Care · doi:10.2337/dc16-2380 · Cited by 43
Wang, C., Ahmed, M. M., Jiang, Q., Lu, N., Tan, C., Gao, Y., Mahmood, Q., Chen, D., Fukunaga, K., Li, M., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12440 · Cited by 42
de Galan, B. E., McCrimmon, R. J., Ibberson, M. R., Heller, S. R., Choudhary, P., Pouwer, F., Speight, J., Carlton, J., Pieber, T. R., Rosilio, M., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14240 · Cited by 44
Self-citationCurrent trends in diabetes mellitus database research in Japan
Kohsaka, S., Morita, N., Okami, S., Kidani, Y., & Yajima, T. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14325 · Cited by 43
Qi, X., Xu, J., Chen, G., Liu, H., Liu, J., Wang, J., Zhang, X., Hao, Y., Wu, Q., & Jiao, M. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01881-y · Cited by 46
An eicosanoid-centric view of atherothrombotic risk factors
Gleim, S., Stitham, J., Tang, W. H., Martin, K. A., & Hwa, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0982-9 · Cited by 43
Munshi, M. N., Kahkoska, A. R., Neumiller, J. J., Alexopoulos, A., Allen, N. A., Cukierman‐Yaffe, T., Huang, E. S., Lee, S. J., Lipska, K. J., McCarthy, L. M., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00372-3 · Cited by 42
Huffel, L. V., Tomson, C., Ruige, J. B., Nistor, I., Biesen, W. V., & Bolignano, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113667 · Cited by 41
McEwan, P., Thorsted, B. L., Wolden, M. L., Jacobsen, J., & Evans, M. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000057 · Cited by 41
Borgquist, O., Wise, M. P., Nielsen, N., Al-Subaie, N., Cranshaw, J. H., Cronberg, T., Glover, G. W., Hassager, C., Kjærgaard, J., Kuiper, M. A., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002367 · Cited by 41
Jensen, M. H., Dethlefsen, C., Hejlesen, O. K., & Vestergaard, P. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01447-x · Cited by 41
Schernthaner, G., Barnett, A. H., Patel, S., Hehnke, U., von Eynatten, M., & Woerle, H. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12321 · Cited by 40
Kenngott, H., Clemens, G., Gondan, M., Senft, J. D., Diener, M. K., Rudofsky, G., Nawroth, P. P., Büchler, M. W., Fischer, L., & Müller-Stich, B. P. (2013) · Trials · doi:10.1186/1745-6215-14-183 · Cited by 40
Meta-analysis: Association between hypoglycaemia and serious adverse events in older patients
Mattishent, K., & Loke, Y. K. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.03.018 · Cited by 41
Cardiac Effects of Sulfonylurea-Related Hypoglycemia
Middleton, T. L., Wong, J., Molyneaux, L. M., Brooks, B. A., Yue, D. K., Twigg, S. M., & Wu, T. (2017) · Diabetes Care · doi:10.2337/dc16-1972 · Cited by 40
Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
Yun, J., & Ko, S. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.1.6 · Cited by 41
Hypoglycemia: Minimizing its impact in type 2 diabetes
Moghissi, E., Ismail-Beigi, F., & Devine, R. C. (2013) · Endocrine Practice · doi:10.4158/ep13005.ra · Cited by 39
Shrinking Fabrication of a Glucose‐Responsive Glucagon Microneedle Patch
Wang, Z., Fu, R., Han, X., Wen, D., Wu, Y., Li, S., & Gu, Z. (2022) · Advanced Science · doi:10.1002/advs.202203274 · Cited by 40
Bolt, J., Carvalho, V., Lin, K., Lee, S. J., & Inglis, C. (2024) · Age and Ageing · doi:10.1093/ageing/afae259 · Cited by 39
Zeyfang, A., Bahrmann, A., & Wernecke, J. (2015) · Diabetologie und Stoffwechsel · doi:10.1055/s-0035-1553883 · Cited by 39
Sulphonylureas in the management of type 2 diabetes: To be or not to be?
Scheen, A. J. (2021) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2021.100002 · Cited by 43
Dickerson, R. N., Wilson, V. C., Maish, G. O., Croce, M. A., Minard, G., & Brown, R. O. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112458526 · Cited by 40
Tsujimoto, T., & Kajio, H. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11408 · Cited by 38
Burt, M. G., Drake, S. M., Aguilar‐Loza, N. R., Esterman, A., Stranks, S. N., & Roberts, G. W. (2015) · Internal Medicine Journal · doi:10.1111/imj.12680 · Cited by 38
Inpatient Glycemic Variability and Long-Term Mortality in Hospitalized Patients with Type 2 Diabetes
Timmons, J. G., Cunningham, S. G., Sainsbury, C. A. R., & Jones, G. C. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.06.013 · Cited by 41
Insulin and Its Cardiovascular Effects: What Is the Current Evidence?
Dongerkery, S. P., Schroeder, P. R., & Shomali, M. E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0955-3 · Cited by 38
Increased risk of stroke in patients with chronic kidney disease after recurrent hypoglycemia
Yu, T., Lin, C., Chang, S., Sung, F., & Kao, C. (2014) · Neurology · doi:10.1212/wnl.0000000000000711 · Cited by 38
Parrinello, C. M., Rastegar, I., Godino, J., Miedema, M. D., Matsushita, K., & Selvin, E. (2015) · Diabetes Care · doi:10.2337/dc15-0016 · Cited by 38
Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes
Wang, J., Huang, C., Hung, Y., Kwok, C., Sun, J., Pei, D., Yang, C.-Y., Chen, C., Lin, C., & Sheu, W. H. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.08.001 · Cited by 40
Lean diabetes in middle-aged adults: A joint analysis of the German DIVE and DPV registries
Hartmann, B., Lanzinger, S., Bramlage, P., Groß, F., Danne, T., Wagner, S., Krakow, D., Zimmermann, A., Malcharzik, C., & Holl, R. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183235 · Cited by 39
Chow, L. S., Zmora, R., Ma, S., Seaquist, E. R., & Schreiner, P. J. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000527 · Cited by 37
Economic burden of hypoglycemia in patients with type 2 diabetes
Liu, S., Zhao, Y., Hempe, J. M., Fonseca, V., & Shi, L. (2012) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.87 · Cited by 37
Qu, F., Shi, Q., Wang, Y., Shen, Y., Zhou, K., Pearson, E. R., & Li, S. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002073 · Cited by 37
Management of older adults with diabetes mellitus: Perspective from geriatric medicine
Umegaki, H. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14283 · Cited by 38
The management of severe hypoglycemia by the emergency system: The HYPOTHESIS study
Marchesini, G., Veronese, G., Forlani, G., Forlani, G., Ricciardi, L. M., & Fabbri, A. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.05.012 · Cited by 37
The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update
Katsiki, N., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660673 · Cited by 37
The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes
Tschöpe, D., Hanefeld, M., Meier, J. J., Gitt, A. K., Halle, M., Bramlage, P., & Schumm‐Draeger, P. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-62 · Cited by 37
Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes
Pena, M. J., de Zeeuw, D., Mischak, H., Jankowski, J., Oberbauer, R. W., Woloszczuk, W., Benner, J., Dallmann, G., Mayer, B., Mayer, G. J., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv252 · Cited by 39
on behalf of the GCKD Study Investigators, Busch, M., Nadal, J., Schmid, M. C., Paul, K., Titze, S. I., Hübner, S., Köttgen, A., Schultheiß, U. T., Baid‐Agrawal, S., et al. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0273-z · Cited by 37
Cultural Differences and Considerations When Initiating Insulin
Rebolledo, J. A., & Arellano, R. (2016) · Diabetes Spectrum · doi:10.2337/diaspect.29.3.185 · Cited by 41
Bi, Y., Wang, G., Liu, X., Meng, W., & Zhang, Q. (2017) · Endocrine · doi:10.1007/s12020-017-1251-3 · Cited by 37
Echouffo-Tcheugui, J. B., Daya, N. R., Lee, A. K., Tang, O., Ndumele, C. E., Windham, B. G., Shah, A. M., & Selvin, E. (2020) · Diabetes Care · doi:10.2337/dc20-0552 · Cited by 37
Glycemic Control during Coronary Artery Bypass Graft Surgery
Lazar, H. L. (2012) · ISRN Cardiology · doi:10.5402/2012/292490 · Cited by 37
Metadata
- Authors
- Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., Grobbee, D. E., Kengne, A. P., Marre, M., & Heller, S.
- Affiliations
- The University of Sydney (AU)
- University Medical Center Utrecht (NL)
- Hôpital Bichat-Claude-Bernard (FR)
- National Health Service (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1410-1418
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2097995302
- Semantic Scholar
- b73e51368b0f6c3d0c425e6670188db927bc8b09
- Cited by
- 1,471
- References
- 31
- Citations by year
- 2026: 33 · 2025: 49 · 2024: 64 · 2023: 60 · 2022: 66 · 2021: 103 · 2020: 119 · 2019: 99 · 2018: 113 · 2017: 103 · 2016: 107 · 2015: 147 · 2014: 106 · 2013: 98 · 2012: 103
- FWCI
- 71.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- severe hypoglycemia, type 2 diabetes, tight glycemic control, macrovascular events, cardiovascular mortality, all-cause mortality, adverse clinical outcomes, diabetes complications, UKPDS
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Gliclazide, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Risk Factors, Vascular Diseases, Proportional Hazards Models, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
